Hematopoietic stem cell (HSC) maintenance depends on extrinsic cues. Currently, only local signals arising from the bone marrow niche have been shown to maintain HSCs. However, it is not known whether systemic factors also sustain HSCs. We assessed the physiological source of thrombopoietin (TPO), a key cytokine required for maintaining HSCs. Using Tpo DsRed-CreER knock-in mice, we showed that TPO is expressed by hepatocytes but not by bone marrow cells. Deletion of Tpo from hematopoietic cells, osteoblasts, or bone marrow mesenchymal stromal cells does not affect HSC number or function. However, when Tpo is deleted from hepatocytes, bone marrow HSCs are depleted. Thus, a cross-organ factor, circulating TPO made in the liver by hepatocytes, is required for bone marrow HSC maintenance. Our results demonstrate that systemic factors, in addition to the local niche, are a critical extrinsic component for HSC maintenance.
H ematopoietic stem cells (HSCs) reside primarily in the bone marrow and are maintained by extrinsic cues that arise from supporting niche cells (1) . Endothelial cells (2, 3) and perivascular mesenchymal stromal cells (2) (3) (4) (5) (6) are critical components of the bone marrow niche. Growing functional genetic evidence suggests that HSCs are maintained largely through signals arising directly from, or mediated through, these local niche cells (7) . However, olfaction maintains hematopoietic progenitors through systemic g-aminobutyric acid (GABA) levels in Drosophila (8) , suggesting that longrange signals may be able to directly maintain mammalian HSCs.
No such distal maintenance factors have yet been identified in the mammalian hematopoietic system, although long-range cues, such as estrogen from the ovaries and erythropoietin from the kidneys, can acutely stimulate HSC proliferation and dictate HSC and progenitor differentiation (9, 10) . Neurotransmitters from the nervous system can mobilize HSCs, but this effect is mediated through mesenchymal stromal cells in the niche (11) . Therefore, evidence indicates roles for long-range cues that modify HSC behavior, but direct evidence for constant maintenance of HSCs by a cross-organ long-range systemic factor is lacking.
Signaling of the hematopoietic cytokine thrombopoietin (TPO) through its receptor c-MPL is essential for thrombopoiesis (12) (13) (14) and HSC maintenance (15) (16) (17) . Patients with loss-of-function mutations in c-MPL or TPO develop congenital amegakaryocytic thrombocytopenia and subsequent bone marrow failure (18) (19) (20) . Tpo mRNA is expressed by multiple cell types, including hepatocytes (14, 21) , osteoblasts (17), megakaryocytes (22, 23) , and stromal cells (21, 24) . However, Tpo is under stringent translational control by inhibitory elements in the 5′ untranslated region (25) , so it is not clear whether any of the above-mentioned cell types actually synthesize TPO protein. been conditionally deleted from any cell types to assess its source for HSC maintenance. Thus, it is not clear how TPO maintains bone marrow HSCs in vivo. Loss of hepatic TPO leads to low platelet counts (26) , showing that TPO from the liver regulates thrombopoiesis. Using quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis, we found that Tpo transcripts were enriched in osteoblasts, mesenchymal stromal cells, and the liver (Fig. 1A and fig. S1 , A and B), consistent with previous reports (14, 17, 21, 27) . To systemically assess the expression of TPO protein, we generated Tpo DsRed-CreER knock-in mice by replacing the stop codon of Tpo with a P2A-DsRed-P2A-CreER cassette ( fig. S1, C to F) . The P2A elements allow the translation of TPO, DsRed, and CreER recombinase under the control of Tpo endogenous regulatory elements. This arrangement enabled us to monitor the translational expression of TPO in vivo. We then generated Tpo DsRed-CreER ;loxpZsGreen mice (Fig. 1B) . Consistent with the low expression level of Tpo in vivo (25) , no DsRed fluorescence was detected (Fig. 1 , C to F). However, upon tamoxifen (TMX) administration to 8-week-old mice, we detected broad and specific expression of ZsGreen in hepatocytes (Fig. 1, G to J, and fig. S1 , G to O). We also observed rare ZsGreen + cells in the kidney ( fig. S1P ). However, no ZsGreen + bone marrow cells could be detected (Fig. 1, K to N, and fig.  S1Q ). Thus, TPO is generated by hepatocytes but not by cells in the bone marrow.
We generated a loss-of-function allele of Tpo generate Tpo − through mating with EIIa-cre mice ( fig. S4D ). As expected, Tpo transcripts were absent from homozygous Tpo −/− mice ( fig. S4E ). Tpo −/− mice had significant reduction of HSCs, MPPs, and megakaryocytes (fig. S4, F to H) to levels nearly identical to those in the Tpo gfp/gfp mice ( fig. S3 ). Recombination of the Tpo fl allele therefore gave a strong loss of Tpo function.
Megakaryocytes have been proposed to be a major source of TPO for HSCs (22, 23) . However, we did not detect any Tpo expression in megakaryocytes by qRT-PCR (Fig. 1A) or by using reporter mice (Fig. 1, K to N) . Nonetheless, we directly tested whether megakaryocytes (or any hematopoietic cells) are sources of TPO for HSC maintenance in vivo by generating Vav1-cre;Tpo fl/gfp mice. Vav1-cre efficiently deleted Tpo from the hematopoietic system ( fig. S5A ). Eight-week-old Vav1-cre;Tpo fl/gfp mice had normal blood cell counts ( fig. S5B) , cellularity, and HSC frequency ( fig. S5, C and D) and normal re- bone marrow (17) , and osteoblasts express Tpo transcripts (Fig. 1A) ; however, we could not detect any Tpo translational activity in osteoblasts from our reporter mice (Fig. 1, K to N) . We directly tested whether deletion of Tpo from osteoblasts affects HSCs. Consistent with previous reports (2, 3), Col2.3-cre recombined efficiently in bone-lining osteoblasts ( fig. S6 , A to G). Eight-week-old Col2.3-cre;Tpo f l/g fp mice had normal blood cell counts ( fig. S6H) , cellularity, and HSC frequency in the bone marrow and spleens (Fig. 2, A and B) . Restricted hematopoietic progenitors were also normal ( fig. S6, I to L). Spleen megakaryocytic cells were unaffected ( fig. S6M ), as were the capacities of bone marrow and spleen cells to form colonies in methylcellulose (Fig. 2C  and fig. S6N ). treated with AAV8-TBG-cre. Data are means ± SD. ns, not significant (P > 0.10). *P < 0.05, **P < 0.01, ***P < 0.001.
cells had normal capacities to reconstitute irradiated recipients (Fig. 2D and fig. S6 , O and P). Thus, osteoblasts are not a critical source of TPO for HSC maintenance. Bone marrow Lepr + mesenchymal stromal cells are a critical source of HSC niche factors, including stem cell factor (SCF) and CXCL12 (2, 3). These cells express Tpo transcripts (Fig. 1A) , although we could not detect Tpo translational activity (Fig. 1, K to N) . We conditionally deleted Tpo from mesenchymal stromal cells by generating Lepr-cre; Tpo fl/gfp mice. Tpo was efficiently deleted from these cells (fig. S7, A to G) . Eight-week-old Lepr-cre;Tpo fl/gfp mice had normal blood cell counts ( fig. S7H) , cellularity, and HSC frequency in the bone marrow and spleens (Fig.  2, E and F) . Restricted hematopoietic progenitors were also normal ( fig. S7, I to L). Spleen megakaryocytic cells were unaffected ( fig. S7M ). Bone marrow and spleen cells from Lepr-cre;Tpo fl/gfp mice formed normal numbers of hematopoietic colonies in methylcellulose ( Fig. 2G and fig. S7N ). Bone marrow cells from Lepr-cre;Tpo fl/gfp mice reconstituted irradiated recipients normally (Fig. 2H and fig.  S7 , O and P). Thus, bone marrow mesenchymal stromal cells are not a critical source of TPO for HSC maintenance.
The above data suggest that TPO produced locally by osteoblasts or mesenchymal stromal cells is not required for HSC maintenance. To test whether systemic TPO generated by the liver is important for HSC maintenance, we generated Alb-cre;Tpo fl/fl mice. As expected (31), Alb-cre recombined specifically and efficiently in hepatocytes but not in the bone marrow (Fig. 3, A to D,  and fig. S8, A to D) . Eight-week-old Alb-cre;Tpo fl/fl mice had a fivefold reduction in platelet count (Fig. 3E and fig. S8E ) and a fivefold reduction in megakaryocytic cells in the bone marrow (Fig. 3F) . Alb-cre;Tpo fl/fl mice exhibited normal bone marrow and spleen cellularity (Fig. 3G) . The frequency of bone marrow HSCs was reduced by a factor of 24 compared with that in controls (Fig. 3H) . LSK progenitors and MPPs were similarly reduced ( fig.  S8 , F and G). CMPs were reduced in the bone marrow, whereas other restricted hematopoietic progenitors appeared normal ( fig. S8H ). Bone marrow and spleen cells from Alb-cre;Tpo fl/fl mice formed fewer colonies in methylcellulose (Fig. 3, I and J). Spleen HSC frequency was normal in Alb-cre;Tpo fl/fl mice (Fig. 3H) , suggesting that there was no compensatory extramedullary hematopoiesis. Spleen CD41 + cell frequency decreased ( fig. S8I ). Bone marrow cells from Alb-cre;Tpo fl/fl mice had severe defects in their ability to reconstitute irradiated recipients (Fig. 3, K and L) . Overall, these data show that hepatic TPO is critical for the maintenance of bone marrow HSCs.
During development, HSCs transiently reside in the fetal liver (32) , where Alb-cre recombines (33). Thus, it is possible that bone marrow HSCs in Alb-cre;Tpo fl/fl mice acquire a persistent defect during development, although global deletion of Tpo has no impact on fetal liver HSCs (16) . Nonetheless, we conditionally deleted Tpo from adult hepatocytes by administering the hepatotropic Crebearing virus AAV8-TBG-cre (34) . Consistent with a prior report (34), we observed specific and efficient recombination in hepatocytes after a single intravenous administration of AAV8-TBG-cre to adult mice (Fig. 4, A to D,  and fig. S9, A to D) .
We administered AAV8-TBG-cre virus once to 8-week-old Tpo fl/fl mice and wild-type littermate control mice and analyzed the mice 4 to 8 weeks later. AAV8-TBG-cre-treated wild-type mice had phenotypes identical to those of buffer-treated Tpo fl/fl mice. These mice were pooled together as controls. Deleting Tpo from adult hepatocytes (AAV8-cre;Tpo fl/fl ) significantly reduced platelet counts ( fig. S9E ). Bone marrow and spleen cellularity did not change (Fig. 4E) . However, AAV8-cre;Tpo fl/fl mice had significant reductions in bone marrow HSC, LSK, MPP, CMP, and CD41 + cell frequencies (Fig. 4F and fig. S9, G to I) . The colony-forming capacities of bone marrow and spleen cells were also reduced (Fig. 4, H and I) . Spleen HSC and CD41 + megakaryocytic cell frequencies trended lower ( Fig. 4G and fig. S9J ). Bone marrow cells from AAV8-cre;Tpo fl/fl mice 2 months after the virus treatment had a significant decrease in their ability to reconstitute irradiated recipients, whereas bone marrow cells from AAV8-cre;Tpo fl/fl mice 1 month after the virus treatment had an intermediate phenotype (Fig. 4J and fig. S9K ). To quantify the frequency of functional HSCs, we performed limit dilution assays. In these assays, the frequencies of longterm multilineage reconstituting cells in bone marrow cells from control and AAV8-cre;Tpo fl/fl mice were 1/87,660 and 1/498,020, respectively, corresponding to a 6-fold reduction (Fig. 4K) . AAV8-cre;Tpo fl/fl mice had no significant difference in Annexin V + bone marrow HSCs compared with controls ( Fig. 4L and fig. S9L ), but HSCs from AAV8-cre;Tpo fl/fl mice cycled more ( Fig. 4M and fig. S9M ). These data indicate that adult HSCs lacking hepatocytederived TPO signal are depleted through loss of quiescence.
Tpo transcription is up-regulated in the bone marrow during hematopoietic stress (21) . We injected TMX-treated Tpo DsRed-CreER ;loxpZsGreen mice with 5-fluorouracil but failed to detect ZsGreen expression in the bone marrow ( fig.  S10 ), suggesting that bone marrow is not a major source of TPO in stress, at least under the conditions we tested. Our data show that hepatocytes are the major functional source of systemic TPO for bone marrow HSC maintenance under steady-state conditions. Further studies are required to determine the role of local and systemic TPO in nonhomeostatic conditions.
